IRIS - Res&Arch Institutional Research Information System - Research & Archive

CATERBI, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.020
EU - Europa 695
AS - Asia 326
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.048
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.014
IE - Irlanda 205
SG - Singapore 124
IT - Italia 114
VN - Vietnam 71
HK - Hong Kong 65
UA - Ucraina 61
FR - Francia 59
SE - Svezia 57
RU - Federazione Russa 56
DE - Germania 50
CN - Cina 40
FI - Finlandia 34
AT - Austria 20
KR - Corea 19
CZ - Repubblica Ceca 17
GB - Regno Unito 11
CA - Canada 6
BE - Belgio 4
CH - Svizzera 3
TR - Turchia 3
UZ - Uzbekistan 3
NL - Olanda 2
ZA - Sudafrica 2
ZW - Zimbabwe 2
AU - Australia 1
EU - Europa 1
GR - Grecia 1
KE - Kenya 1
LB - Libano 1
PL - Polonia 1
Totale 2.048
Salva come PNG Salva come JPEG
Città #
Chandler 268
Dublin 204
San Mateo 119
Singapore 101
Dong Ket 71
Perugia 62
Hong Kong 56
Boardman 52
Santa Clara 46
Medford 44
Princeton 43
Altamura 37
Lawrence 36
Wilmington 36
Andover 34
Jacksonville 28
Munich 24
Ann Arbor 22
Beijing 20
Vienna 19
Seoul 18
Saint Petersburg 15
Brno 13
Dallas 12
Des Moines 12
Norwalk 11
Ashburn 10
San Paolo di Civitate 10
Falls Church 9
Helsinki 9
Ottawa 6
Redwood City 6
Brussels 4
Olomouc 4
Houston 3
Izmir 3
Redmond 3
Den Haag 2
Fremont 2
Harare 2
Los Angeles 2
Moscow 2
New York 2
Pretoria 2
Tappahannock 2
Woodbridge 2
Central District 1
Chengdu 1
Edinburgh 1
Falkenstein 1
Frankfurt Am Main 1
Frankfurt am Main 1
Las Vegas 1
London 1
Ludwigshafen 1
Nairobi 1
Nuremberg 1
Samara 1
Secaucus 1
Shanghai 1
Simi Valley 1
Washington 1
Totale 1.504
Salva come PNG Salva come JPEG
Nome #
Development of virulence-attenuated Plasmodium berghei parasites 93
Disruption of plasmepsin-4 and merozoites surface protein-7 genes in Plasmodium berghei induces combined virulence-attenuated phenotype 75
Plasmepsin 4 Deficient Plasmodium berghei Are Virulence-Attenuated and Induce Protective Immunity against Experimental Malaria 72
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study. 71
Sequential disruption of the blood stage genes Plasmepsin 4 and MSP7 in Plasmodium berghei induces a progressively virulence-attenuated phenotype 69
Balance between Regulatory T and Th17 Cells in Systemic Lupus Erythematosus: The Old and the New 69
Plasmepsin 4 deficient Plasmodium berghei are virulence-attenuated and induce protective immunity against experimental malaria 67
IL-17-producing CD4-CD8- T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary Sjogren's syndrome. 67
Altered Immunoregulation in Rheumatoid Arthritis: The Role of Regulatory T Cells and Proinflammatory Th17 Cells and Therapeutic Implications. 65
PROTEIN EXPRESSION PROFILE OF PLASMEPSIN IV KNOCK DOWN PLASMODIUM BERGHEI PARASITE AND IMMUNOREACTIVE IDENTIFICATION 64
Characterization of circulating endothelial microparticles and endothelial progenitor cells in primary Sjögren's syndrome: new markers of chronic endothelial damage? 63
Sequential disruption of PM4 and MSP7 in Plasmodium berghei induces a progressive virulence-attenuated phenotype. 61
The circulating interferon-inducible protein IFI16 correlates with clinical and serological features in Rheumatoid Arthritis 61
A8. 6 A novel therapeutic approach in systemic rheumatic autoimmune disorders: encapsulated human umbilical cord wharton jelly-derived mesenchymal stem cells 60
Serum interleukin-17 in primary Sjögren's syndrome: association with disease duration and parotid gland swelling. 59
Characterization of a new regulatory CD4+ T cell subset in primary Sjogren's syndrome. 57
Association between clinical, histopathological and molecular features in primary Sjögren’s Syndrome: a retrospective study 56
T Regulatory and T Helper 17 Cells in Primary Sjögren's Syndrome: Facts and Perspectives 55
GALACTOXYLOMANNAN IS A POWERFUL IMMUNE SYSTEM MODULATOR ABLE TO REBALANCE TREG/TH17 RATIO IN RHEUMATOID ARTHRITIS 54
Plasmepsin 4 Deficient Plasmodium berghei Are Virulence-Attenuated and Induce Protective Immunity against Experimental Malaria 53
Anticyclic Citrullinated Peptide Antibodies in Patients with Rheumatic Diseases other than Rheumatoid Arthritis: Clinical or Pathogenic Significance? 53
Circulating interferon-inducible protein IFI16 correlates with clinical and serological features in rheumatoid arthritis. 52
Circulating Endothelial Microparticles and Endothelial Progenitors Cells in Primary SjÖGren's Syndrome: New Markers of Chronic Endothelial Damage? 50
IL-17 producing-DN T cells are expanded in the blood, infiltrate salivary glands and are resistant to corticosteroids in sjÖgren’s syndrome 47
Endothelial Microparticles and Circulating Endothelial Progenitor Cells in Primary SjöGren’s Syndrome Patients: Correlation with Clinical and Immunological Features 46
A6.2 Purified microbial capsular polysaccharide Galactoxylomannan (GalXM) inhibits the effector T lymphocyte arm and potentiates the regulatory counterpart in rheumatoid arthritis 46
Immunomodulatory effects of human umbilical cord wharton jelly-derived mesenchymal stem cells (HUCMS) on circulating T-cell subsets in patients with sjögren’s syndrome 43
CD3+CD4–CD8–Double Negative Th17 Cells: New Insights in the Pathogenesis of Primary Sjögren’s Syndrome 43
CD4-CD8- T-cells in primary Sjögren's syndrome: Association with the extent of glandular involvement 42
IL-17 Producing Pathogenic T Lymphocytes Co-Express CD20 and are Depleted by Rituximab in Primary sjögren's Syndrome: A Novel Target for an Old Weapon 40
Restoration of t cell substes of patients with type 1 diabetes mellitus by microencapsulated human umbilical cord wharton jelly-derived mesenchymal stem cells: An in vitro study 39
The role of T helper 17 cell subsets in Sjogren's syndrome: similarities and differences between mouse model and humans 39
Telocytes in minor salivary glands of primary Sjögren's syndrome: Association with the extent of inflammation and ectopic lymphoid neogenesis 37
Interferon gamma-inducible protein 16 in primary Sjögren's syndrome: a novel player in disease pathogenesis? 36
TELOCYTES IN MINOR SALIVARY GLANDS OF PATIENTS WITH PRIMARY SJOGREN'S SYNDROME: ASSOCIATION WITH THE EXTENT OF INFLAMMATION AND ECTOPIC LYMPHONEOGENESIS 36
Role of Platelets in the Pathogenesis of Osteoarthritis and Biological Effects of Hyaluronic Acid: in Vivo and in Vitro Study 35
Mobilization of Lymphatic Endothelial Precursors Cells and Lymphatic Neovascularization in Primary Sjögren's Syndrome 33
Selective elimination of pathogenic TH17 cells from peripheral blood of rheumatoid arthritis patients by a purified fungal polysaccharide 31
Pathogenic role of IL-17 producing double negative (DN) T cells in primary sjögren’s syndrome 30
Interferon Gamma-Inducible Protein 16 (IFI16) in Primary SjÖgren's Syndrome: A Novel Player in Disease Pathogenesis? 29
Interferon Gamma-Inducible Protein 16 (IFI16) in Rheumatoid Arthritis: A Novel Biomarker for Pulmonary Involvement? 26
Mobilization of lymphatic endothelial precursor cells and lymphatic neovascularization in primary Sjögren's syndrome 24
Interleukin (IL)-17-producing pathogenic T lymphocytes co-express CD20 and are depleted by rituximab in primary Sjögren's syndrome: A pilot study 20
Totale 2.168
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.992
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.992
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202085 0 0 0 0 0 5 10 27 12 18 9 4
2020/2021255 1 8 10 9 91 12 10 4 17 6 13 74
2021/2022370 3 81 11 12 12 7 2 130 3 11 44 54
2022/2023720 45 147 4 81 54 70 0 37 250 0 21 11
2023/2024263 21 30 9 0 1 17 50 9 8 8 49 61
2024/2025244 20 64 16 47 85 12 0 0 0 0 0 0
Totale 2.168